Spinal cord stimulation in Parkinson’s disease: a review of the preclinical and clinical data and future prospects

Abstract Parkinson’s disease (PD) is a progressive neurodegenerative disease with an incidence of 0.1 to 0.2% over the age of 40 and a prevalence of over 1 million people in North America. The most common symptoms include tremor, bradykinesia, rigidity, pain, and postural instability, with significa...

Full description

Bibliographic Details
Main Authors: Yi Cai, Rajiv D. Reddy, Vishal Varshney, Krishnan V. Chakravarthy
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Bioelectronic Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s42234-020-00041-9
id doaj-714689d5bf054834bf016f94834aa64a
record_format Article
spelling doaj-714689d5bf054834bf016f94834aa64a2020-11-25T03:20:42ZengBMCBioelectronic Medicine2332-88862020-03-016111010.1186/s42234-020-00041-9Spinal cord stimulation in Parkinson’s disease: a review of the preclinical and clinical data and future prospectsYi Cai0Rajiv D. Reddy1Vishal Varshney2Krishnan V. Chakravarthy3Department of Anesthesiology and Pain Medicine, University of California San Diego Health SciencesDepartment of Anesthesiology and Pain Medicine, University of California San Diego Health SciencesDepartment of Anesthesiology, Perioperative and Pain Medicine, University of CalgaryDepartment of Anesthesiology and Pain Medicine, University of California San Diego Health SciencesAbstract Parkinson’s disease (PD) is a progressive neurodegenerative disease with an incidence of 0.1 to 0.2% over the age of 40 and a prevalence of over 1 million people in North America. The most common symptoms include tremor, bradykinesia, rigidity, pain, and postural instability, with significant impact in quality of life and mortality. To date there is ongoing research to determine the optimum therapy for PD. In this review we analyze the current data in the use of spinal cord stimulation (SCS) therapy for treatment for Parkinsonian symptoms. We specifically address waveform pattern, anatomic location and the role of spinal cord stimulation (SCS) as a salvage therapy after deep brain stimulation (DBS) therapy. We also outline current experimental evidence from preclinical research highlighting possible mechanisms of beneficial effects of SCS in this context. Though the use of SCS therapy is in its infancy for treatment of PD, the data points to an exciting area for ongoing research and exploration with positive outcomes from both cervical and thoracic tonic and BURSTDR spinal cord stimulation.http://link.springer.com/article/10.1186/s42234-020-00041-9NeuromodulationSpinal cord stimulationParkinson’s diseaseGaitSalvage therapy
collection DOAJ
language English
format Article
sources DOAJ
author Yi Cai
Rajiv D. Reddy
Vishal Varshney
Krishnan V. Chakravarthy
spellingShingle Yi Cai
Rajiv D. Reddy
Vishal Varshney
Krishnan V. Chakravarthy
Spinal cord stimulation in Parkinson’s disease: a review of the preclinical and clinical data and future prospects
Bioelectronic Medicine
Neuromodulation
Spinal cord stimulation
Parkinson’s disease
Gait
Salvage therapy
author_facet Yi Cai
Rajiv D. Reddy
Vishal Varshney
Krishnan V. Chakravarthy
author_sort Yi Cai
title Spinal cord stimulation in Parkinson’s disease: a review of the preclinical and clinical data and future prospects
title_short Spinal cord stimulation in Parkinson’s disease: a review of the preclinical and clinical data and future prospects
title_full Spinal cord stimulation in Parkinson’s disease: a review of the preclinical and clinical data and future prospects
title_fullStr Spinal cord stimulation in Parkinson’s disease: a review of the preclinical and clinical data and future prospects
title_full_unstemmed Spinal cord stimulation in Parkinson’s disease: a review of the preclinical and clinical data and future prospects
title_sort spinal cord stimulation in parkinson’s disease: a review of the preclinical and clinical data and future prospects
publisher BMC
series Bioelectronic Medicine
issn 2332-8886
publishDate 2020-03-01
description Abstract Parkinson’s disease (PD) is a progressive neurodegenerative disease with an incidence of 0.1 to 0.2% over the age of 40 and a prevalence of over 1 million people in North America. The most common symptoms include tremor, bradykinesia, rigidity, pain, and postural instability, with significant impact in quality of life and mortality. To date there is ongoing research to determine the optimum therapy for PD. In this review we analyze the current data in the use of spinal cord stimulation (SCS) therapy for treatment for Parkinsonian symptoms. We specifically address waveform pattern, anatomic location and the role of spinal cord stimulation (SCS) as a salvage therapy after deep brain stimulation (DBS) therapy. We also outline current experimental evidence from preclinical research highlighting possible mechanisms of beneficial effects of SCS in this context. Though the use of SCS therapy is in its infancy for treatment of PD, the data points to an exciting area for ongoing research and exploration with positive outcomes from both cervical and thoracic tonic and BURSTDR spinal cord stimulation.
topic Neuromodulation
Spinal cord stimulation
Parkinson’s disease
Gait
Salvage therapy
url http://link.springer.com/article/10.1186/s42234-020-00041-9
work_keys_str_mv AT yicai spinalcordstimulationinparkinsonsdiseaseareviewofthepreclinicalandclinicaldataandfutureprospects
AT rajivdreddy spinalcordstimulationinparkinsonsdiseaseareviewofthepreclinicalandclinicaldataandfutureprospects
AT vishalvarshney spinalcordstimulationinparkinsonsdiseaseareviewofthepreclinicalandclinicaldataandfutureprospects
AT krishnanvchakravarthy spinalcordstimulationinparkinsonsdiseaseareviewofthepreclinicalandclinicaldataandfutureprospects
_version_ 1724617107747897344